Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.45 USD | -7.75% | -8.00% | -72.03% |
May. 10 | Earnings Flash (APDN) APPLIED DNA SCIENCES Reports Q2 Revenue $929,631 | MT |
May. 10 | Applied DNA Sciences Regains Nasdaq Minimum Bid Price Requirement | MT |
Chart calendar Applied DNA Sciences, Inc.
Upcoming events on Applied DNA Sciences, Inc.
Past events on Applied DNA Sciences, Inc.
2024-05-10 04:05 pm | Q2 2024 Earnings Release |
2024-04-24 | Reverse Split: 1 of 20 |
2024-04-15 10:00 am | Extraordinary Shareholders Meeting |
2024-02-08 04:30 pm | Q1 2024 Earnings Call |
2024-02-08 04:05 pm | Q1 2024 Earnings Release |
2023-12-07 04:30 pm | Q4 2023 Earnings Call |
2023-12-07 04:05 pm | Q4 2023 Earnings Release |
2023-09-19 10:00 am | Annual General Meeting |
2023-08-10 04:30 pm | Q3 2023 Earnings Call |
2023-08-10 04:05 pm | Q3 2023 Earnings Release |
2023-06-21 04:30 pm | Maxim Group Virtual Healthcare Conference |
2023-05-11 04:30 pm | Q2 2023 Earnings Call |
2023-05-11 04:05 pm | Q2 2023 Earnings Release |
2023-02-09 04:30 pm | Q1 2023 Earnings Call |
2023-02-09 04:05 pm | Q1 2023 Earnings Release |
2023-01-08 | JP Morgan Healthcare Conference |
2022-12-14 04:30 pm | FY 2022 Earnings Call |
2022-12-14 04:10 pm | FY 2022 Earnings Release |
2022-09-22 10:00 am | Annual General Meeting |
2022-09-13 02:00 pm | H.C. Wainwright Global Investment Conference |
Annual results
Fiscal Period | September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 5,39 5,83 -7.56% | 1,93 2,33 -16.94% | 9,03 8,28 8.98% | 18,2 18,7 -2.91% | 13,4 14,3 -6.32% | 5,02 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -9,12 -8,72 -4.66% | -12,5 -11,6 -7.87% | -13,1 -11,5 -14.32% | -14,0 -12,3 -13.85% | -11,0 -10,3 -6.53% | -14,2 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,62 -8,86 2.72% | -13,0 -12,1 -7.97% | -14,3 -12,6 -13.3% | -8,27 -10,4 20.56% | -10,0 -9,91 -1.17% | -12,3 |
Net income Million USD | Released Forecast Spread | -8,93 -8,86 -0.84% | -13,0 -12,1 -7.96% | -14,3 -12,6 -13.33% | -8,38 -10,5 20.36% | -9,95 -9,86 -0.86% | -12,9 |
EPS USD | Released Forecast Spread | -194 -206 5.74% | -66,4 -61,0 -8.85% | -41,4 -37,0 -11.89% | -18,6 -23,8 21.85% | -15,2 -15,2 0% | -13,0 |
Announcement Date | 12/12/19 | 17/12/20 | 09/12/21 | 14/12/22 | 07/12/23 | - |
Quarterly results
Fiscal Period | September | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 4,17 4,02 3.64% | 6,15 4,50 36.64% | 4,30 3,60 19.31% | 3,56 4,10 -13.28% | 5,26 4,17 26.22% | 4,41 4,13 6.84% | 2,92 2,56 14.07% | 0,78 1,68 -53.6% | 0,89 0,78 14.84% | 0,95 | 1,18 | 2,00 | 1,40 | 1,70 |
EBIT Million USD | Released Forecast Spread | -4,63 -2,02 -129.4% | -1,99 -2,74 27.18% | -2,84 -2,89 1.83% | -4,37 -2,81 -55.77% | -1,22 -3,75 67.48% | -2,70 -2,59 -4.34% | -2,86 -3,13 8.63% | -4,17 -3,50 -19.17% | -3,79 -4,13 8.21% | -3,61 | -3,55 | -3,26 | ||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,72 -2,04 -131.57% | -1,76 -2,76 36.2% | -1,12 -2,89 61.09% | -0,66 -2,81 76.31% | -3,84 -3,75 -2.55% | 0,55 -2,59 121.27% | -3,11 -3,13 0.47% | -3,62 -3,50 -3.3% | -1,13 -4,13 72.62% | -3,75 | -3,75 | -3,72 | ||
Net income Million USD | Released Forecast Spread | -4,72 -2,04 -131.61% | -1,87 -2,76 32.25% | -1,12 -2,89 61.11% | -0,66 -2,81 76.36% | -3,84 -3,75 -2.53% | 0,59 -2,59 122.7% | -3,10 -3,13 0.93% | -3,59 -3,50 -2.64% | -1,11 -4,13 73.23% | -3,61 | -3,55 | -3,26 | ||
EPS USD | Released Forecast Spread | -12,6 -5,33 -136.25% | -4,60 -6,67 31% | -2,60 -7,10 63.38% | 0,20 -4,70 104.26% | -6,00 -5,80 -3.45% | 1,00 -4,00 125% | -4,80 -4,80 0% | -5,20 -5,30 1.89% | -1,80 -6,20 70.97% | -4,50 | -3,70 | -3,00 | -5,80 | -2,20 |
Announcement Date | 10/02/22 | 12/05/22 | 11/08/22 | 14/12/22 | 09/02/23 | 11/05/23 | 10/08/23 | 07/12/23 | 08/02/24 | - | - | - | - | - |
Past sector events for Applied DNA Sciences, Inc.
2024-05-09 | DIASORIN S.P.A.: Q1 2024 Earnings Release |
2024-05-07 04:05 pm | MYRIAD GENETICS, INC.: Q1 2024 Earnings Release |
2024-05-02 04:05 pm | CASTLE BIOSCIENCES, INC.: Q1 2024 Earnings Release |
2024-05-02 07:00 am | LANTHEUS HOLDINGS, INC.: Q1 2024 Earnings Release |
2024-04-30 04:05 pm | 10X GENOMICS, INC.: Q1 2024 Earnings Release |
2024-04-29 | ASSURE TECH (HANGZHOU) CO., LTD.: Q1 2024 Earnings Release |
2024-04-29 | SHANDONG ORIENTAL OCEAN SCI-TECH CO., LTD.: Q1 2024 Earnings Release |
2024-04-29 | SHANDONG ORIENTAL OCEAN SCI-TECH CO., LTD.: Q4 2023 Earnings Release |
2024-04-29 | ZHEJIANG ORIENT GENE BIOTECH CO.,LTD: Q4 2023 Earnings Release |
2024-04-29 | CHEMCLIN DIAGNOSTICS CO., LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- APDN Stock
- Calendar Applied DNA Sciences, Inc.